Paloma Partners Management CO Verastem, Inc. Transaction History

Paloma Partners Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$1.26 - $3.38 $30,279 - $81,224	-24,031 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.86 - $1.44 $20,666 - $34,604	24,031 New	24,031 $32,000
Q3 2019 Nov 14, 2019	SELL	$1.21 - $1.59 $252,164 - $331,356	-208,400 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.25 - $3.14 $204,638 - $514,052	163,711 Added 366.33%	208,400 $315,000
Q1 2019 May 15, 2019	BUY	$2.79 - $4.09 $124,682 - $182,778	44,689 New	44,689 $132,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.